HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Signatures of CD4+ T and B cells are associated with distinct stages of chronic chagasic cardiomyopathy.

AbstractIntroduction:
Chagas disease is a neglected parasitic disease caused by Trypanosoma cruzi. While most patients are asymptomatic, around 30% develop Chronic Chagasic Cardiomyopathy (CCC).
Methods:
Here, we employed high-dimensional flow cytometry to analyze CD4+ T and B cell compartments in patients during the chronic phase of Chagas disease, presenting the asymptomatic and mild or moderate/severe cardiac clinical forms.
Results:
Effector CD27-CD4+ T cells were expanded in both CCC groups, and only mild CCC patients showed higher frequencies of effector memory and T follicular helper (Tfh) cells than healthy donors (CTL) and asymptomatic patients. Unsupervised analysis confirmed these findings and further revealed the expansion of a specific subpopulation composed of Tfh, transitional, and central memory CD4+ T cells bearing a phenotype associated with strong activation, differentiation, and exhaustion in patients with mild but not moderate/severe CCC. In contrast, patients with mild and moderate/severe CCC had lower frequencies of CD4+ T cells expressing lower levels of activation markers, suggesting resting status, than CTL. Regarding the B cell compartment, no alterations were found in naïve CD21-, memory cells expressing IgM or IgD, marginal zone, and plasma cells in patients with Chagas disease. However, expansion of class-switched activated and atypical memory B cells was observed in all clinical forms, and more substantially in mild CCC patients.
Discussion:
Taken together, our results showed that T. cruzi infection triggers changes in CD4+ T and B cell compartments that are more pronounced in the mild CCC clinical form, suggesting an orchestrated cellular communication during Chagas disease.
Conclusion:
Overall, these findings reinforce the heterogeneity and complexity of the immune response in patients with chronic Chagas disease and may provide new insights into disease pathology and potential markers to guide clinical decisions.
AuthorsIsabela Natália Pascoal Campos do Vale, Gregório Guilherme Almeida, Inga Rimkute, Thomas Liechti, Fernanda Fortes de Araújo, Luara Isabela Dos Santos, Priscilla Miranda Henriques, Manoel Otávio da Costa Rocha, Silvana Maria Elói-Santos, Olindo Assis Martins Filho, Mario Roederer, Alan Sher, Dragana Jankovic, Andréa Teixeira Carvalho, Lis Ribeiro do Valle Antonelli
JournalFrontiers in immunology (Front Immunol) Vol. 15 Pg. 1385850 ( 2024) ISSN: 1664-3224 [Electronic] Switzerland
PMID38726014 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2024 Vale, Almeida, Rimkute, Liechti, Araújo, Santos, Henriques, Rocha, Elói-Santos, Martins−Filho, Roederer, Sher, Jankovic, Teixeira−Carvalho and Antonelli.
Topics
  • Humans
  • Chagas Cardiomyopathy (immunology)
  • Male
  • Middle Aged
  • Female
  • CD4-Positive T-Lymphocytes (immunology)
  • Adult
  • B-Lymphocytes (immunology)
  • Trypanosoma cruzi (immunology)
  • Chronic Disease
  • Aged
  • Lymphocyte Activation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: